These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 16902173)

  • 1. White matter lesions are associated with progression of medial temporal lobe atrophy in Alzheimer disease.
    de Leeuw FE; Korf E; Barkhof F; Scheltens P
    Stroke; 2006 Sep; 37(9):2248-52. PubMed ID: 16902173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.
    Tam CW; Burton EJ; McKeith IG; Burn DJ; O'Brien JT
    Neurology; 2005 Mar; 64(5):861-5. PubMed ID: 15753423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. White matter lesions are prevalent but differentially related with cognition in aging and early Alzheimer disease.
    Burns JM; Church JA; Johnson DK; Xiong C; Marcus D; Fotenos AF; Snyder AZ; Morris JC; Buckner RL
    Arch Neurol; 2005 Dec; 62(12):1870-6. PubMed ID: 16344345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medial temporal lobe atrophy increases the specificity of cerebrospinal fluid biomarkers in Alzheimer disease with minor cerebrovascular changes.
    Zhang Y; Londos E; Minthon L; Wattmo C; Blennow K; Liu HJ; Bronge L; Aspelin P; Wahlund LO
    Acta Radiol; 2009 Jul; 50(6):674-81. PubMed ID: 19455444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medial temporal atrophy but not memory deficit predicts progression to dementia in patients with mild cognitive impairment.
    Geroldi C; Rossi R; Calvagna C; Testa C; Bresciani L; Binetti G; Zanetti O; Frisoni GB
    J Neurol Neurosurg Psychiatry; 2006 Nov; 77(11):1219-22. PubMed ID: 16891386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of mild cognitive impairment to dementia: contribution of cerebrovascular disease compared with medial temporal lobe atrophy.
    Staekenborg SS; Koedam EL; Henneman WJ; Stokman P; Barkhof F; Scheltens P; van der Flier WM
    Stroke; 2009 Apr; 40(4):1269-74. PubMed ID: 19228848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioural and psychological symptoms are not related to white matter hyperintensities and medial temporal lobe atrophy in Alzheimer's disease.
    Staekenborg SS; Gillissen F; Romkes R; Pijnenburg YA; Barkhof F; Scheltens P; van der Flier WM
    Int J Geriatr Psychiatry; 2008 Apr; 23(4):387-92. PubMed ID: 17907266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medial temporal lobe atrophy is independently associated with behavioural and psychological symptoms in Alzheimer's disease.
    García-Alberca JM; Florido M; Cáceres M; Sánchez-Toro A; Lara JP; García-Casares N
    Psychogeriatrics; 2019 Jan; 19(1):46-54. PubMed ID: 30084177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes mellitus, hypertension and medial temporal lobe atrophy: the LADIS study.
    Korf ES; van Straaten EC; de Leeuw FE; van der Flier WM; Barkhof F; Pantoni L; Basile AM; Inzitari D; Erkinjuntti T; Wahlund LO; Rostrup E; Schmidt R; Fazekas F; Scheltens P;
    Diabet Med; 2007 Feb; 24(2):166-71. PubMed ID: 17257279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood pressure, white matter lesions and medial temporal lobe atrophy: closing the gap between vascular pathology and Alzheimer's disease?
    Korf ES; Scheltens P; Barkhof F; de Leeuw FE
    Dement Geriatr Cogn Disord; 2005; 20(6):331-7. PubMed ID: 16179827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the Spectrum of Subcortical Hyperintensities and Cognitive Decline.
    Chen YC; Tsao HH; Chu YC; Wang JJ; Lee JD; Chang PY; Hsu WC
    J Neuropsychiatry Clin Neurosci; 2018; 30(2):130-138. PubMed ID: 29061091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The usefulness of visual rating of posterior atrophy in predicting rapid cognitive decline in Alzheimer disease: A preliminary study.
    Suh J; Park YH; Kim HR; Jang JW; Kang MJ; Yang J; Baek MJ; Kim S
    Int J Geriatr Psychiatry; 2019 Apr; 34(4):625-632. PubMed ID: 30714196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSF and MRI markers independently contribute to the diagnosis of Alzheimer's disease.
    Schoonenboom NS; van der Flier WM; Blankenstein MA; Bouwman FH; Van Kamp GJ; Barkhof F; Scheltens P
    Neurobiol Aging; 2008 May; 29(5):669-75. PubMed ID: 17208336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain atrophy accelerates cognitive decline in cerebral small vessel disease: the LADIS study.
    Jokinen H; Lipsanen J; Schmidt R; Fazekas F; Gouw AA; van der Flier WM; Barkhof F; Madureira S; Verdelho A; Ferro JM; Wallin A; Pantoni L; Inzitari D; Erkinjuntti T;
    Neurology; 2012 May; 78(22):1785-92. PubMed ID: 22592361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linear measures of temporal lobe atrophy on brain magnetic resonance imaging (MRI) but not visual rating of white matter changes can help discrimination of mild cognitive impairment (MCI) and Alzheimer's disease (AD).
    Saka E; Dogan EA; Topcuoglu MA; Senol U; Balkan S
    Arch Gerontol Geriatr; 2007; 44(2):141-51. PubMed ID: 16723158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of medial temporal atrophy and white matter hyperintensities on the cognitive functions in patients with Alzheimer's disease.
    Shim YS; Youn YC; Na DL; Kim SY; Cheong HK; Moon SY; Park KW; Ku BD; Lee JY; Jeong JH; Kang H; Kim EJ; Lee JS; Go SM; Kim SH; Cha KR; Seo SW
    Eur Neurol; 2011; 66(2):75-82. PubMed ID: 21778730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medial temporal lobe atrophy in vascular dementia: visual temporal lobe rating scale.
    Cho H; Kwon JH; Seo HJ
    Arch Gerontol Geriatr; 2009; 48(3):415-8. PubMed ID: 18468705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine.
    Blasko I; Jellinger K; Kemmler G; Krampla W; Jungwirth S; Wichart I; Tragl KH; Fischer P
    Neurobiol Aging; 2008 Jan; 29(1):1-11. PubMed ID: 17055615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of white matter hyperintensity on medial temporal lobe atrophy in Alzheimer's disease.
    Jang JW; Kim S; Na HY; Ahn S; Lee SJ; Kwak KH; Lee MA; Hsiung GY; Choi BS; Youn YC
    Eur Neurol; 2013; 69(4):229-35. PubMed ID: 23344183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medial temporal lobe atrophy relates to executive dysfunction in Alzheimer's disease.
    Oosterman JM; Oosterveld S; Rikkert MG; Claassen JA; Kessels RP
    Int Psychogeriatr; 2012 Sep; 24(9):1474-82. PubMed ID: 22717328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.